{"schema_version":"1","generated_at":"2026-11-21T20:10:52.132Z","data_as_of":null,"url":"https://www.findmykol.com/kol/julie-taguchi","json_url":"https://www.findmykol.com/kol/julie-taguchi/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"julie-taguchi","name":"Julie Taguchi","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Sansum Medical Clinic","institution_url":"https://www.findmykol.com/institution/sansum-medical-clinic","city":"Santa Barbara","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"on_file":["npi","openalex"],"values":"Shown on the profile page to a signed-in account."},"summary":"Julie Taguchi is an Oncology physician affiliated with Sansum Medical Clinic. OpenAlex indexes 12 publications with 1,105 citations (h-index 5); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":12,"cited_by_count":1105,"h_index":5,"latest_activity_year":2025,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT04190927","title":"A New Hormone Replacement Paradigm: Physiologic Restoration Study","phase":"PHASE4","status":"UNKNOWN","role":"Overall official","sponsor":"Women's Hormone Network","source_url":"https://clinicaltrials.gov/study/NCT04190927","trial_url":"https://www.findmykol.com/trial/NCT04190927"},{"nct":"NCT02645175","title":"Evaluate the Safety Profile and Ability of TW1025 Oral Solution to Decrease Fatigue","phase":"PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"Meriyana Bio Inc.","source_url":"https://clinicaltrials.gov/study/NCT02645175","trial_url":"https://www.findmykol.com/trial/NCT02645175"}],"source":"trials"},"payments":{"company_count":2,"program_years":{"first":2021,"last":null},"rows_total":11,"shown":3,"withheld":8,"rows":[{"payer":"Janssen Biotech, Inc.","program_year":2025,"amount_usd":123.33,"payment_count":1},{"payer":"Janssen Biotech, Inc.","program_year":2024,"amount_usd":124.98,"payment_count":1},{"payer":"Daiichi Sankyo","program_year":2023,"amount_usd":124951,"payment_count":126}],"source":"payments"},"prescribing":{"data_year":2023,"areas_total":3,"areas_shown":3,"areas":[{"area":"Genitourinary & hormones","share_pct":63.6,"classes_total":1,"classes":[{"class":"Progesterone","setting":"prescribed","share_pct":63.6,"drugs":[{"name":"Progesterone","share_pct":100}],"max_beneficiaries":13}]},{"area":"Metabolism & gastrointestinal","share_pct":18.2,"classes_total":1,"classes":[{"class":"Biguanide (metformin)","setting":"prescribed","share_pct":18.2,"drugs":[{"name":"Metformin Hcl","share_pct":100}],"max_beneficiaries":null}]},{"area":"Sensory organs","share_pct":18.2,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":18.2,"drugs":[{"name":"Hydrocortisone","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2020,"office_pct":98.6,"facility_pct":1.4},"source":"medicare"},"publications":{"total":12,"shown":5,"withheld":7,"matched_by":"OpenAlex author record","recent":[{"title":"Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study","year":2020,"journal":"The Lancet Oncology","source_url":"https://doi.org/10.1016/s1470-2045(19)30863-0","status":"verified"},{"title":"Assessing Patient Readiness to Engage in End-of-life Discussions: Development and Pilot Testing of the End-of-Life Readiness Assessment (ERA) Survey (GP719)","year":2020,"journal":"Journal of Pain and Symptom Management","source_url":"https://doi.org/10.1016/j.jpainsymman.2020.04.142","status":"verified"},{"title":"DEVELOPMENT AND PILOT TESTING OF THE END-OF-LIFE READINESS ASSESSMENT (ERA) SURVEY","year":2019,"journal":"Innovation in Aging","source_url":"https://doi.org/10.1093/geroni/igz038.020","status":"verified"},{"title":"Phase Ib/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of HER2-positive breast cancer with brain metastases (TRIO-US B-09)","year":2018,"journal":"Therapeutic Advances in Medical Oncology","source_url":"https://doi.org/10.1177/1758835918807339","status":"verified"},{"title":"A Novel Combined Approach for Metastatic Breast Cancer with Dural and Leptomeningeal Disease with an Impressive Clinical Outcome: A Case Study","year":2018,"journal":"Journal of Cancer Therapy","source_url":"https://doi.org/10.4236/jct.2018.93025","status":"verified"}],"source":"works"},"similar":[{"name":"Mukul Gupta","slug":"mukul-gupta","institution":"Sansum Medical Clinic","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/mukul-gupta","json_url":"https://www.findmykol.com/kol/mukul-gupta/profile.json"},{"name":"Andrew Mester","slug":"andrew-mester","institution":"Sansum Medical Clinic","specialty":"Otolaryngology","url":"https://www.findmykol.com/kol/andrew-mester","json_url":"https://www.findmykol.com/kol/andrew-mester/profile.json"},{"name":"Gregory Cogert","slug":"gregory-cogert","institution":"Sansum Medical Clinic","specialty":"Clinical Cardiac Electrophysiology","url":"https://www.findmykol.com/kol/gregory-cogert","json_url":"https://www.findmykol.com/kol/gregory-cogert/profile.json"},{"name":"Scott Tobis","slug":"scott-tobis","institution":"Sansum Medical Clinic","specialty":"Urology","url":"https://www.findmykol.com/kol/scott-tobis","json_url":"https://www.findmykol.com/kol/scott-tobis/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Stuart Orkin","slug":"stuart-orkin","institution":"Harvard Medical School","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stuart-orkin","json_url":"https://www.findmykol.com/kol/stuart-orkin/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":8,"publications":7}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023}},"methodology_url":"https://www.findmykol.com/about#methodology"}